Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 44, Issue 3, 2004, Pages 205-209

  Scott, Fergus ^a   Peters, Helen ^a   Bonifacio, Michael ^b   McLennan, Andrew ^a   Boogert, Antheunis ^a   Kesby, Greg ^a   Anderson, John ^a  

^a Sydney Ultrasound for Women   (Australia)

^b The Sydney Institute   (Australia)

Author keywords

Down syndrome; Free beta human chorionic gonadotrophin; Nuchal translucency; Pregnancy associated plasma protein A; Screening

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; BIOCHEMISTRY; BLOOD ANALYSIS; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FEMALE; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; KARYOTYPE 45,X; KARYOTYPE 47,XXX; KARYOTYPE 47,XXY; KARYOTYPE 47,XYY; MATERNAL AGE; MEDICAL ASSESSMENT; MEDICAL SPECIALIST; OBSTETRIC CARE; POPULATION RESEARCH; PRIORITY JOURNAL; PRIVATE PRACTICE; PROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY ANALYSIS; TRIPLOIDY; TRISOMY 21; UNITED KINGDOM;

ADOLESCENT; ADULT; AUSTRALIA; BLOOD CHEMICAL ANALYSIS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME ABERRATIONS; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MASS SCREENING; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES;

EID: 3242804530     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2004.00205.x     Document Type: Article

References (11)

1. Wald NJ, Huttly WJ, Hackshaw AK. Antenatal screening for Down's syndrome with the quadruple test. Lancet. 2003; 361: 835-836.
2. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet. 1998; 352: 343-346.
3. Smidt-Jensen S, Permin M, Philip J, Lundsteen C, Zachary JM, Fowler SE, Gruning K. Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling. Lancet. 1992; 340: 1237-1244.
4. Kornman LH, Wortelboer MJ, Beekhuis JR, Morssink LP, Mantingh A. Women's opinions and the implications of first-versus second-trimester screening for fetal Down's syndrome. Prenat Diagn. 1997; 17: 1011-1018.
5. Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. Br J Obstet Gynaecol. 2000; 107: 1271-1275.
6. Hyett J, Thilaganathan B. First trimester screening for fetal abnormalities. Curr Opin Obstet Gynecol. 1999; 11: 563-569.
7. Chitty L. Prenatal screening for chromosome abnormalities. Br Med Bull. 1998; 54: 839-856.
8. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta human chorionic gonadotrophin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. 1999; 13: 231-237.
9. Bindra R, Heath V, Liao A, Spencer K, Nicolaides KH. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15,030 pregnancies. Ultrasound Obstet Gynecol. 2002; 20: 219-225.
10. von Kaisenberg CS, Gasiorek-Wiens A, Bielicki M et al. Screening for trisomy 21 by maternal age, nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicentre study. J Matern Fetal Neonatal Med. 2002; 12: 89-94.
11. Cicero S, Bindra R, Rembouskos G, Spencer K, Nicolaides KH. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11-14 weeks. Prenat Diagn. 2003; 23: 306-310.